Ishii K et al. |
Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties. |
1998 |
Drug Dev Ind Pharm |
pmid:15605442
|
Highleyman L |
FDA issues Hismanal warning. Food and Drug Administration. |
1998 |
BETA |
pmid:11365263
|
Niang M et al. |
[Painful nodular lesions]. |
1998 |
Rev Med Interne |
pmid:9793156
|
Saika T et al. |
[A mechanism of clarithromycin resistance in Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9796191
|
Sevin E et al. |
Co-detection of Helicobacter pylori and of its resistance to clarithromycin by PCR. |
1998 |
FEMS Microbiol. Lett. |
pmid:9742711
|
Hiratsuka T et al. |
[Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone]. |
1998 |
Nihon Kokyuki Gakkai Zasshi |
pmid:9742869
|
Torresani C |
Clarithromycin: a new perspective in rosacea treatment. |
1998 |
Int. J. Dermatol. |
pmid:9620480
|
Tsuneoka H et al. |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy]. |
1998 |
Kansenshogaku Zasshi |
pmid:9621560
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Butt AA |
Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. |
1998 |
Am. J. Med. Sci. |
pmid:9427575
|
Sonnenberg A et al. |
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group. |
1998 |
Arch. Intern. Med. |
pmid:9570170
|
Dal Bo' N et al. |
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks? |
1998 |
J. Gastroenterol. Hepatol. |
pmid:9570242
|
Kato S et al. |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. |
1998 |
Helicobacter |
pmid:9844069
|
Gisbert JP et al. |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. |
1998 |
Rev Clin Esp |
pmid:9844453
|
Ieshiro R et al. |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer--the second report]. |
1998 |
Jpn J Antibiot |
pmid:9597484
|
Sakamoto M et al. |
[Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597485
|
Teramoto S et al. |
[Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer]. |
1998 |
Jpn J Antibiot |
pmid:9597486
|
Tatsis G et al. |
Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections. |
1998 |
J. Antimicrob. Chemother. |
pmid:9579716
|
Perng CL et al. |
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. |
1998 |
Dig. Dis. Sci. |
pmid:9539638
|
Lilley LL and Guanci R |
A dangerous combination. |
1998 |
Am J Nurs |
pmid:9612423
|
Sheu BS et al. |
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. |
1998 |
J. Formos. Med. Assoc. |
pmid:9585678
|
Hasegawa M et al. |
[In vitro activities of faropenem against clarithromycin resistance Helicobacter pylori isolates]. |
1998 |
Kansenshogaku Zasshi |
pmid:9585692
|
Cecchi R and Torelli E |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. |
1998 |
J. Dermatol. |
pmid:9714985
|
Dore MP et al. |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. |
1998 |
Clin. Infect. Dis. |
pmid:9675458
|
Hashimoto Y |
[Eradication therapies for Helicobacter pylori]. |
1998 |
Kansenshogaku Zasshi |
pmid:9695480
|
Wakasugi H et al. |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. |
1998 |
Clin. Pharmacol. Ther. |
pmid:9695727
|
Hsieh PF et al. |
Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. |
1998 |
J. Formos. Med. Assoc. |
pmid:9700240
|
Guerriero SE et al. |
Two cases of clarithromycin-induced digoxin toxicity. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324195
|
Anzueto A et al. |
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group. |
1997 Sep-Oct |
Clin Ther |
pmid:9385486
|
Svoboda P et al. |
Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. |
1997 May-Jun |
Hepatogastroenterology |
pmid:9222709
|
Best LM et al. |
Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218854
|
O'Brien B et al. |
Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218858
|
al-Humayyd MS |
Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat. |
1997 Mar-Apr |
Chemotherapy |
pmid:9084915
|
Grunden JW and Fisher KA |
Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220046
|
Tartaglione T |
Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. |
1997 Jul-Aug |
Clin Ther |
pmid:9377608
|
Mikasa K et al. |
Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. |
1997 Jul-Aug |
Chemotherapy |
pmid:9209786
|
Nawarskas JJ et al. |
Digoxin toxicity secondary to clarithromycin therapy. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220047
|
Dautzenberg B et al. |
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections. |
1997 Jan-Feb |
Infection |
pmid:9039532
|
Kearsley NL et al. |
Comparison of clarithromycin suspension and amoxycillin syrup for the treatment of children with pharyngitis and/or tonsillitis. |
1997 Apr-May |
Br J Clin Pract |
pmid:9293051
|
Gisbert JP et al. |
[What is the current role of clarithromycin in the eradication of Helicobacter pylori?]. |
1997 |
Rev Esp Enferm Dig |
pmid:9221019
|
Matsumoto T et al. |
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:9228971
|
Kadayifçi A et al. |
Clarithromycin-induced fever in a patient with Helicobacter pylori gastritis. |
1997 |
Ann Pharmacother |
pmid:9184727
|
Götz JM et al. |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. |
1997 |
Gut |
pmid:9203935
|
Katari SR et al. |
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. |
1997 |
Clin Transplant |
pmid:9193849
|
Verhaegen J et al. |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae. |
1997 |
Acta Clin Belg |
pmid:9204588
|
Kim MJ et al. |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment. |
1997 |
Gastroenterology |
pmid:9207259
|
Gotoh A et al. |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. |
1997 |
Microbiol. Immunol. |
pmid:9087962
|
Driscoll MS and Tyring SK |
Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. |
1997 |
J. Am. Acad. Dermatol. |
pmid:9091495
|
Gui GP et al. |
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096189
|
Chaisson RE et al. |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. |
1997 |
AIDS |
pmid:9147422
|
Lazzaroni M et al. |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer. |
1997 |
Am. J. Gastroenterol. |
pmid:9128316
|
DÃaz F et al. |
[Cat-scratch disease. A report of 4 cases and a review of the literature]. |
1997 |
Rev Clin Esp |
pmid:9102668
|
Szczebara F et al. |
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9105846
|
Arguedas A et al. |
Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion. |
1997 |
J Chemother |
pmid:9106017
|
Horgen L et al. |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium. |
1997 |
Res. Microbiol. |
pmid:9765852
|
Denys A |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. |
1997 |
Otolaryngol Pol |
pmid:9757681
|
Pendland SL et al. |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. |
1997 |
J. Clin. Microbiol. |
pmid:9350781
|
Kubas G and Gospodarek T |
[The use of clarithromycin and amoxycillin in pediatric acute otitis media]. |
1997 |
Otolaryngol Pol |
pmid:9757683
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Burman WJ et al. |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements. |
1997 |
Int. J. Tuberc. Lung Dis. |
pmid:9441082
|
Brady RC et al. |
Facial sporotrichoid infection with Mycobacterium marinum. |
1997 |
J. Pediatr. |
pmid:9042142
|
Suzuki K et al. |
Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages. |
1997 |
Int. J. Tuberc. Lung Dis. |
pmid:9441102
|
Axon AT et al. |
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042977
|
Gotoh A et al. |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori. |
1997 |
Microbiol. Immunol. |
pmid:9444328
|
Labenz J et al. |
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042978
|
Labenz J et al. |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9042979
|
Prattichizzo FA et al. |
[Carditis associated with Mycoplasma pneumoniae infection. Clinical aspects and therapeutic problems]. |
1997 |
Minerva Cardioangiol |
pmid:9446067
|
Erah PO et al. |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection. |
1997 |
J. Antimicrob. Chemother. |
pmid:9044021
|
Genné D et al. |
Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9447898
|
Roche B et al. |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. |
1997 |
Rev Rhum Engl Ed |
pmid:9051864
|
Ridgway GL et al. |
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. |
1997 |
J. Antimicrob. Chemother. |
pmid:9484871
|
Goh KL et al. |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection? |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663838
|
Visalli MA et al. |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9294703
|
Kolkman JJ et al. |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663840
|
Miyaji H et al. |
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9663841
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Buckley MJ et al. |
Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. |
1997 |
Dig. Dis. Sci. |
pmid:9365144
|
Misiewicz JJ et al. |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. |
1997 |
Gut |
pmid:9462204
|
Loo VG et al. |
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. |
1997 |
J. Antimicrob. Chemother. |
pmid:9462442
|
Hoffner SE et al. |
In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis. |
1997 |
J. Antimicrob. Chemother. |
pmid:9462443
|
Torresani C et al. |
Clarithromycin versus doxycycline in the treatment of rosacea. |
1997 |
Int. J. Dermatol. |
pmid:9466207
|
Tzivras M et al. |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9471024
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
Cammarota G et al. |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication. |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9476192
|
Hotz J |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram]. |
1997 |
Fortschr. Med. |
pmid:9480263
|
Thornsberry C et al. |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9458982
|
Briant C et al. |
Pericarditis as a manifestation of Lyme disease. |
1997 |
J Emerg Nurs |
pmid:9460386
|
Sousa C et al. |
[Cholestatic hepatitis probably induced by clarithromycin]. |
1997 |
Gastroenterol. Clin. Biol. |
pmid:9587506
|
Barry AL et al. |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9405952
|
Mitsuyama T et al. |
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9338603
|
Ando H et al. |
[Changes in serum anti-Helicobacter pylori IgG antibody, pepsinogen I, and pepsinogen II after eradication therapy of Helicobacter pylori]. |
1997 |
Nihon Shokakibyo Gakkai Zasshi |
pmid:9396326
|
Hirakawa T |
[Diagnosis and treatment of Helicobacter pylori]. |
1997 |
Nippon Ika Daigaku Zasshi |
pmid:9283206
|
Meyer JM et al. |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9210696
|
Chimura T |
[Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection]. |
1997 |
Jpn J Antibiot |
pmid:9212369
|
Lim AG et al. |
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9218079
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Sekkarie MA |
Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin. |
1997 |
Am. J. Kidney Dis. |
pmid:9292575
|
Akaki T et al. |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice]. |
1997 |
Kekkaku |
pmid:9293712
|